{
  "type": "hyp",
  "text": "BPDE treatment caused induction of both AP-1 and NF-kappaB activity as determined by luciferase reporter assay and only NF-kappaB induction in response to BPDE was significantly unaltered by TSC phenolic fraction whereas AP-1 induction remains unaltered.\n",
  "self": {
    "NER": {
      "answers": [
        "TSC"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What treatment did not alter NF-kappaB activity?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "BPDE treatment",
        "induction",
        "both AP-1 and NF-kappaB activity",
        "luciferase reporter assay",
        "only NF-kappaB induction",
        "response",
        "BPDE",
        "TSC phenolic fraction",
        "AP-1 induction"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What caused induction of both AP-1 and NF-kappaB activity?",
          "What did BPDE cause?",
          "What did BPDE cause in response to TSC phenolic fraction?",
          "What method determined NF-kappaB activity in response to BPDE?",
          "What was significantly unaltered by TSC phenolic fraction?",
          "What was significantly unaltered by TSC phenolic fraction?",
          "What treatment caused induction of both AP-1 and NF-kappaB activity",
          "What did BPDE treatment not alter NF-kappaB activity?",
          "What is the only activity that is not altered by BPDE?"
        ]
      }
    }
  },
  "asked": {
    "What phenolic fraction significantly attenuated NF-kappaB activity?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.004004716873168945,
        "ground_truth": {
          "TSC": {
            "bertscore": 0.6862372159957886,
            "f1": 0
          }
        }
      }
    },
    "What caused induction of both AP-1 and NF-kappaB activity?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "BPDE treatment",
        "answerability": 0.9664407968521118,
        "ground_truth": {
          "BPDE treatment": {
            "bertscore": 1.0000001192092896,
            "f1": 1.0
          }
        }
      }
    },
    "What did BPDE cause?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "induction of both AP-1 and NF-kappaB activity",
        "answerability": 0.9759288430213928,
        "ground_truth": {
          "induction": {
            "bertscore": 0.6504998207092285,
            "f1": 0.25
          }
        }
      }
    },
    "What did BPDE cause induction of?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "AP-1 and NF-kappaB",
        "answerability": 0.9789632558822632,
        "ground_truth": {
          "both AP-1 and NF-kappaB activity": {
            "bertscore": 0.8950482606887817,
            "f1": 0.7499999999999999
          }
        }
      }
    },
    "What method determined AP-1 and NF-kappaB activity?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "luciferase reporter assay",
        "answerability": 0.9902952909469604,
        "ground_truth": {
          "luciferase reporter assay": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What was significantly attenuated by TSC phenolic fraction?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0029456615447998047,
        "ground_truth": {
          "only NF-kappaB induction": {
            "bertscore": 0.6484457850456238,
            "f1": 0
          }
        }
      }
    },
    "What is the only significant change in NF-kappaB activity in response to": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.536116898059845,
        "ground_truth": {
          "response": {
            "bertscore": 0.7024294137954712,
            "f1": 0
          }
        }
      }
    },
    "What treatment caused induction of both AP-1 and NF-kappaB activity": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "BPDE treatment",
        "answerability": 0.810055673122406,
        "ground_truth": {
          "BPDE": {
            "bertscore": 0.8883084058761597,
            "f1": 0.6666666666666666
          }
        }
      }
    },
    "What was the only treatment that reduced NF-kappaB activity?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.3366474509239197,
        "ground_truth": {
          "TSC phenolic fraction": {
            "bertscore": 0.6184144020080566,
            "f1": 0
          }
        }
      }
    },
    "What activity is not altered by BPDE?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "AP-1",
        "answerability": 0.9281573295593262,
        "ground_truth": {
          "AP-1 induction": {
            "bertscore": 0.8769432306289673,
            "f1": 0.6666666666666666
          }
        }
      }
    }
  }
}